| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |